Huangming Hong

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Venues

Leukemia

Cancer management and research

American journal of hematology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zegeng Chen, He Huang, Huageng Huang, Le Yu, Huawei Weng, Jian Xiao, Liqun Zou, Huilai Zhang, Chaoyong Liang, Hui Zhou, Hongqiang Guo, Zhao Wang, Zhi-Ming Li, Tao Wu, Hongyu Zhang, Huijing Wu, Zhigang Peng, Linzhu Zhai, Xinggui Chen, Zhi-Wei Liang, Huangming Hong, Tongyu Lin
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma. Leukemia 38 (4) (2024)
Zegeng Chen, He Huang, Huageng Huang, Le Yu, Huawei Weng, Jian Xiao, Liqun Zou, Huilai Zhang, Chaoyong Liang, Hui Zhou, Hongqiang Guo, Zhao Wang, Zhi-Ming Li, Tao Wu, Hongyu Zhang, Huijing Wu, Zhigang Peng, Linzhu Zhai, Xinggui Chen, Zhi-Wei Liang, Huangming Hong, Tongyu Lin
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma. Leukemia (2024)
Zegeng Chen, He Huang, Huageng Huang, Le Yu, Huawei Weng, Jian Xiao, Liqun Zou, Huilai Zhang, Chaoyong Liang, Hui Zhou, Hongqiang Guo, Zhao Wang, Zhi-Ming Li, Tao Wu, Hongyu Zhang, Huijing Wu, Zhigang Peng, Linzhu Zhai, Xinggui Chen, Zhi-Wei Liang, Huangming Hong, Tongyu Lin
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma. Leukemia 38 (4) (2024)
Zegeng Chen, He Huang, Huageng Huang, Le Yu, Huawei Weng, Jian Xiao, Liqun Zou, Huilai Zhang, Chaoyong Liang, Hui Zhou, Hongqiang Guo, Zhao Wang, Zhi-Ming Li, Tao Wu, Hongyu Zhang, Huijing Wu, Zhigang Peng, Linzhu Zhai, Xinggui Chen, Zhi-Wei Liang, Huangming Hong, Tongyu Lin
Genomic features reveal potential benefit of adding anti-PD-1 immunotherapy to treat non-upper aerodigestive tract natural killer/T-cell lymphoma. Leukemia 38 (4) (2024)
Huawei Weng, Prem Raj Shrestha, Huangming Hong, Zegeng Chen, Le Yu, Yuyi Yao, Zhihui Zhang, Liqun Zou, Bo Zhu, Hui Zhou, Xianling Liu, Yao Liu, Hongqiang Guo, He Huang, Tongyu Lin
Primary breast diffuse large B-cell lymphoma in the rituximab era: A retrospective study of the Chinese Southwest Oncology Group. Cancer medicine (2023)
Jing-Quan Lim, Dachuan Huang, Jason Yongsheng Chan, Yurike Laurensia, Esther Kam Yin Wong, Daryl Ming Zhe Cheah, Burton Kuan Hui Chia, Wen-Yu Chuang, Ming-Chung Kuo, Yi-Jiun Su, Qing-Qing Cai, Yanfen Feng, Huilan Rao, Li-Na Feng, Pan-Pan Wei, Jie-Rong Chen, Bo-Wei Han, Guo-Wang Lin, Jun Cai, Yu Fang, Jing Tan, Huangming Hong, Yanhui Liu, Fen Zhang, Wenyu Li, Michelle L M Poon, Siok Bian Ng, Anand Jeyasekharan, Jeslin Chian Hung Ha, Lay Poh Khoo, Suk Teng Chin, Wan Lu Pang, Rebecca Kee, Chee Leong Cheng, Nicholas Francis Grigoropoulos, Tiffany Tang, Miriam Tao, Mohamad Farid, Kia Joo Puan, Jie Xiong, Wei-Li Zhao, Chiea Chuen Khor, William Hwang, Won Seog Kim, Elias Campo, Patrick Tan, Bin Tean Teh, Wee-Joo Chng, Olaf Rötzschke, Thomas Tousseyn, Hui-Qiang Huang, Steve Rozen, Soon Thye Lim, Lee-Yung Shih, Jin-Xin Bei, Choon Kiat Ong
A genomic-augmented multivariate prognostic model for the survival of natural-killer/T-cell lymphoma patients from an international cohort. American journal of hematology 97 (9) (2022)
Ning Xie, Tao Qin, Wei Ren, Herui Yao, Yunfang Yu, Huangming Hong
Efficacy and Safety of Cyclin-Dependent Kinases 4 and 6 Inhibitors in HR+/HER2- Advanced Breast Cancer. Cancer management and research 12 (2020)
Sio Teng Lam, He Huang, Xiaojie Fang, Zhao Wang, Huangming Hong, Quanguang Ren, Ying Tian, Suxia Lin, Tongyu Lin
A New Immunological Prognostic Model Based on Immunohistochemistry for Extranodal Natural Killer/T-Cell Lymphoma Patients After Non-Anthracycline-Based Chemotherapy. Cancer management and research 12 (2020)
Huangming Hong, Xiaojie Fang, He Huang, Zhao Wang, Tongyu Lin, Herui Yao
The derived neutrophil-to-lymphocyte ratio is an independent prognostic factor in patients with angioimmunoblastic T-cell lymphoma. British journal of haematology 189 (5) (2020)
Huangming Hong, He Huang, Xiaojie Fang, Zhao Wang, Sheng Ye, Hongyu Zhang, Ying Huang, Hongqiang Guo, Xinggui Chen, Chaoyong Liang, Xingxiang Pu, Yabing Cao, Suxia Lin, Xueying Li, Quanguang Ren, Qing Liu, Tongyu Lin
A prognostic index for nasal-type early-stage extranodal natural killer/T-cell lymphoma: A multicenter study. American journal of hematology 94 (5) (2019)

Huangming Hong.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Huangming Hong